All Pharma articles – Page 9
-
NewsRegulator accused of presiding over 'utter shambles' says it was 'duty bound' to act on IV supplies
A regulator has defended its actions which caused delays to the supply of life-saving intravenous feed for hundreds of patients with HSJ learning some are now being admitted to hospital.
-
NewsKey caesarean drug unavailable for two weeks
A drug used in most caesarean sections in the UK is expected to be unavailable for the next two weeks, prompting concerns some trusts may run out of supplies.
-
HSJ AwardsHSJ Patient Safety Awards 2019: Best Partnership Solution Improving Patient Safety
Leeds Teaching Hospitals Trust Parkinson’s QI collaborative: Collaborative to improve hospital care for people with Parkinson’s
-
HSJ AwardsHSJ Patient Safety Awards 2019: Improving Safety in Medicines Management Initiative
Winner Arden and GEM CSU with Norwich CCG: Improving patient safety through annual care home medication reviews
-
NewsStevens: Government must re-boot ‘no-deal’ Brexit plan ‘within weeks’
Ministers must act “very, very soon” to re-boot contingency plans for a no deal Brexit if the NHS and suppliers are to be ready for the UK to crash out of the EU on 31 October, NHS England’s chief executive has warned.
-
HSJ AwardsWorking at scale to improve medicines management
AT Medics won the 2018 HSJ Award for Optimisation of Medicines Management for creating a central pharmacy team that worked to improve the quality of prescribing, reports Claire Read
-
HSJ AwardsHSJ Value Awards 2019: Pharmacy and medicines optimisation award
Winner Salford Royal Foundation Trust: Salford polycystic kidney disease multidisciplinary clinic – pharmacy-led drug education and management When a National Institute for Health and Care Excellence-approved treatment for polycystic kidney disease became available in 2015, Salford Royal FT set up specialist clinics and ensured patients had information to help them ...
-
NewsMinister announces new national innovation 'unit'
A new national “unit” is being established, with its own “chief executive”, to oversee innovation and medicines, the Department of Health and Social Care has announced.
-
NewsLegal action firm among winners for largest medicines procurement
Three pharmaceutical companies – including one which took NHS England to court over the design of a billion-pound tender – have been awarded contracts to supply drugs as part of a bid to eradicate hepatitis C by 2025.
-
NewsCCGs could face fresh pressures to fund costly drug
Clinical commissioning groups could face renewed pressure to fund an expensive thyroid drug under NHS England revised guidance, due to be published shortly.
-
NewsRegulator criticised for 'unbelievably arrogant' approval process
Patient groups have called NHS England “unbelievably arrogant” for failing to listen to patients during drug funding reviews.
-
CommentLondon is facing up to reality in the HIV prevention fight
In response to recent headlines on the PreP trial expansion, Cllr Ray Puddifoot says London boroughs are committed to playing a full part in it
-
NewsDHSC sets up hotline for Brexit disruption to supplies
NHS suppliers have been told to contact a new 24/7 call centre run by the Department of Health and Social Care if they experience disruption to their deliveries following a no-deal Brexit.
-
NewsCouncils seek NHS funding to cover drug trial pressures
Councils in London are seeking additional funding from NHS England to help deal with cost pressures arising from trials for an HIV drug.
-
NewsCCGs under strain again from generic drug prices
The number of generic drugs being sold above national tariff rose to its highest rate in over two years at the start of 2019, despite national efforts to cut this number.
-
CommentDillon: We should have thought harder on safe staffing
This week: Sir Andrew Dillon, chief executive of the National Institute for Health and Care Excellence
-
HSJ AwardsHSJ Partnership Awards 2019: Best Pharmaceutical Partnership with the NHS
WINNER: Gilead Sciences, CGL and the NHS: Gilead partnering with Drug Treatment Services (and the NHS) to support eliminating Hepatitis C (HCV)
-
HSJ InteractiveBest value biologics: an HSJ and Novartis roundtable
An HSJ and Novartis roundtable discussed that “best value biologics” actually means successfully creating value across the whole health and social care system – not merely assessing the comparative cost of drugs
-
CommentHow staff and patients use workarounds to keep the NHS on track
Dr Beth Fylan on how “props and bridges” used by staff and patients promote the NHS’s safe functioning – despite the pressure borne from busy ward environments, multiple discharges and complicated medicines
-
NewsSteve Field: Digital GPs overseas remain a danger
Regulators and policymakers are at a loss for how to stop people accessing dangerous medicines using online services overseas, the outgoing chief inspector of GPs has said.